Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAGEA12 is a cancer/testis antigen that is normally expressed only in germ cells, but is aberrantly activated in various cancers. It plays a role in tumor progression by repressing tumor suppressor genes and promoting cell viability. MAGEA12 regulates the cell cycle and its expression is associated with poor prognosis in cancer. It is considered a potential target for immunotherapy, but with risks of off-tumor toxicity.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanoma-associated antigen family A member 12 (MAGEA12).